تقرير تحليل حجم السوق العالمية لاختبار وظائف الرئة، وحصتها السوقية، واتجاهاتها - نظرة عامة على الصناعة وتوقعاتها حتى عام 2032

Request for TOC طلب جدول المحتويات Speak to Analyst تحدث إلى المحلل Free Sample Report تقرير عينة مجاني Inquire Before Buying استفسر قبل Buy Now اشتري الآن

تقرير تحليل حجم السوق العالمية لاختبار وظائف الرئة، وحصتها السوقية، واتجاهاتها - نظرة عامة على الصناعة وتوقعاتها حتى عام 2032

  • Medical Devices
  • Published Report
  • Sep 2024
  • Global
  • 350 الصفحات
  • عدد الجداول: 984
  • عدد الأرقام: 37

Global Pulmonary Function Testing Market

حجم السوق بالمليار دولار أمريكي

CAGR :  % Diagram

Chart Image USD 3.88 Billion USD 6.23 Billion 2024 2032
Diagram فترة التنبؤ
2025 –2032
Diagram حجم السوق (السنة الأساسية)
USD 3.88 Billion
Diagram حجم السوق (سنة التنبؤ)
USD 6.23 Billion
Diagram CAGR
%
Diagram اللاعبين الرئيسيين في الأسواق
  • BD
  • SCHILLER CoSMED srl
  • NSPIRE Healthcare
  • MGC DIAGNOSTICS CORPORATION
  • ndd Medical Technologies

تجزئة سوق اختبار وظائف الرئة العالمي، حسب النوع (الأجهزة، الخدمات، والبرمجيات)، نوع المريض (أطفال، بالغون، وكبار السن)، التطبيق (مرض الانسداد الرئوي ومرض الرئة التقييدي)، المستخدم النهائي (المستشفيات، العيادات التخصصية، مختبرات التشخيص، مؤسسات الرعاية المنزلية، وغيرها) - اتجاهات الصناعة وتوقعاتها حتى عام 2032

سوق اختبار وظائف الرئة

حجم سوق اختبار وظائف الرئة

  • تم تقييم حجم سوق اختبار وظائف الرئة العالمي بـ 3.88 مليار دولار أمريكي في عام 2024  ومن المتوقع أن يصل إلى  6.23 مليار دولار أمريكي بحلول عام 2032 ، بمعدل نمو سنوي مركب قدره 6.10٪ خلال الفترة المتوقعة
  • يتم دعم نمو السوق إلى حد كبير من خلال التبني المتزايد والتقدم التكنولوجي في تشخيصات الجهاز التنفسي ومراقبة المرضى، مما يؤدي إلى زيادة الرقمنة في كل من الإعدادات السريرية والمنزلية
  • علاوة على ذلك، يُسهم الطلب المتزايد من المستهلكين على حلول دقيقة وغير جراحية ومتكاملة لتقييم وظائف الرئة في ترسيخ مكانة اختبار وظائف الرئة (PFT) كأداة تشخيص ومراقبة حديثة ومفضلة. تُسرّع هذه العوامل المتقاربة من الإقبال على حلول اختبار وظائف الرئة، مما يُعزز نمو هذا القطاع بشكل كبير.

تحليل سوق اختبار وظائف الرئة

  • أجهزة اختبار وظائف الرئة (PFT)، التي توفر قياسًا دقيقًا لحجم الرئة وسعتها ومعدلات التدفق وتبادل الغازات، هي مكونات حيوية بشكل متزايد في تشخيصات الجهاز التنفسي الحديثة وأنظمة مراقبة المرضى في كل من الإعدادات السريرية والمنزلية نظرًا لدقتها المحسنة وعدم تدخلها ورؤيتها الشاملة لصحة الرئة.
  • إن الطلب المتزايد على أجهزة PFT مدفوع في المقام الأول بالاعتماد الواسع النطاق على تقنيات التشخيص المتقدمة، والانتشار المتزايد لأمراض الجهاز التنفسي بين المستهلكين، والتفضيل المتزايد للكشف المبكر عن أمراض الرئة وإدارتها.
  • تهيمن أمريكا الشمالية على سوق اختبار وظائف الرئة بحصة سوقية تبلغ 38.9% وتتميز بانتشار واسع لأمراض الجهاز التنفسي وبنية تحتية قوية للرعاية الصحية وحضور قوي للاعبين الرئيسيين في الصناعة
  • من المتوقع أن تكون منطقة آسيا والمحيط الهادئ أسرع المناطق نموًا في سوق اختبار وظائف الرئة خلال الفترة المتوقعة، مع معدل نمو سنوي مركب متوقع بنسبة 7.7٪، بسبب زيادة التحضر وارتفاع الدخول المتاحة وتحسين البنية التحتية للرعاية الصحية.
  • هيمن قطاع تطبيقات مرض الانسداد الرئوي على سوق أنظمة اختبار وظائف الرئة في عام 2024 بحصة سوقية بلغت 39.8%، مدفوعًا بالانتشار العالمي المرتفع لمرض الانسداد الرئوي المزمن (COPD) والربو وضرورة المراقبة المستمرة وإدارة هذه الحالات المزمنة.

نطاق التقرير وتجزئة سوق اختبار وظائف الرئة

صفات

رؤى السوق الرئيسية لاختبار وظائف الرئة

القطاعات المغطاة

  • حسب النوع: الأجهزة والخدمات والبرامج
  • حسب نوع المريض: الأطفال، والبالغين، وكبار السن
  • حسب التطبيق: مرض الانسداد الرئوي ومرض الرئة التقييدي
  • حسب المستخدم النهائي: المستشفى، والعيادات المتخصصة، ومختبرات التشخيص، ومؤسسات الرعاية المنزلية، وغيرها

الدول المغطاة

أمريكا الشمالية

  • نحن
  • كندا
  • المكسيك

أوروبا

  • ألمانيا
  • فرنسا
  • المملكة المتحدة
  • هولندا
  • سويسرا
  • بلجيكا
  • روسيا
  • إيطاليا
  • إسبانيا
  • ديك رومى
  • بقية أوروبا

آسيا والمحيط الهادئ

  • الصين
  • اليابان
  • الهند
  • كوريا الجنوبية
  • سنغافورة
  • ماليزيا
  • أستراليا
  • تايلاند
  • أندونيسيا
  • فيلبيني
  • بقية منطقة آسيا والمحيط الهادئ

الشرق الأوسط وأفريقيا

  • المملكة العربية السعودية
  • الإمارات العربية المتحدة
  • جنوب أفريقيا
  • مصر
  • إسرائيل
  • بقية الشرق الأوسط وأفريقيا

أمريكا الجنوبية

  • البرازيل
  • الأرجنتين
  • بقية أمريكا الجنوبية

اللاعبون الرئيسيون في السوق

  • شركة زول الطبية (الولايات المتحدة)
  • شركة تليفليكس المحدودة (الولايات المتحدة)
  • شركة القاهرة (الولايات المتحدة)
  • شركة COSMED srl (إيطاليا)
  • شركة شيلر إيه جي (سويسرا)
  • شركة GANSHORN Medizin Electronic GmbH (ألمانيا)
  • شركة بولم ون للأجهزة الطبية المتقدمة (إسرائيل)
  • ndd Medical Technologies (سويسرا)
  • كوكو PFT (المملكة المتحدة)
  • شركة جيراثيرم الطبية (ألمانيا)
  • شركة إيكو ميديكس إيه جي (سويسرا)
  • مورغان ساينتيفيك (الولايات المتحدة)
  • سيبل، ساو (إسبانيا)
  • كلاريتي ميديكال (الهند)
  • علوم البيانات الدولية (الولايات المتحدة)
  • إنجمار الطبية (الولايات المتحدة)
  • نظام جيه كي الطبي (الهند)
  • شركة MEC المحدودة (المملكة المتحدة)
  • ميدلاين إندستريز، إل بي (الولايات المتحدة)
  • المسجلات وأنظمة الرعاية الطبية (الهند)
  • فيتالوغراف (أيرلندا)
  • المعدات الطبية أوروبا GMBH (ألمانيا)
  • شركة تشيست مي (اليابان)
  • شركة كونتيك للأنظمة الطبية المحدودة (الصين)
  • فوكودا دينشي (اليابان)

فرص السوق

  • تزايد الطلب على أجهزة PFT المحمولة والمنزلية
  • دمج الذكاء الاصطناعي والصحة الرقمية

مجموعات معلومات البيانات ذات القيمة المضافة

بالإضافة إلى الرؤى حول سيناريوهات السوق مثل القيمة السوقية ومعدل النمو والتجزئة والتغطية الجغرافية واللاعبين الرئيسيين، فإن تقارير السوق التي تم تنظيمها بواسطة Data Bridge Market Research تشمل أيضًا تحليلًا متعمقًا من الخبراء، وتحليل التسعير، وتحليل حصة العلامة التجارية، واستطلاع رأي المستهلكين، وتحليل التركيبة السكانية، وتحليل سلسلة التوريد، وتحليل سلسلة القيمة، ونظرة عامة على المواد الخام / المواد الاستهلاكية، ومعايير اختيار البائعين، وتحليل PESTLE، وتحليل Porter، والإطار التنظيمي.

اتجاهات سوق اختبار وظائف الرئة

"الاعتماد المتزايد على أجهزة PFT المحمولة والمنزلية"

  • من الاتجاهات المهمة والمتسارعة في سوق اختبار وظائف الرئة العالمي، تزايد استخدام أجهزة اختبار وظائف الرئة المحمولة والمنزلية، مدفوعًا بالطلب المتزايد على الرعاية التنفسية اللامركزية والمتمحورة حول المريض. يتيح هذا التحول إمكانية أوسع للوصول إلى خدمات الاختبار، لا سيما في المناطق النائية أو التي تعاني من نقص الخدمات، ويتماشى مع التركيز العالمي على الرعاية الصحية عن بُعد وإدارة الأمراض المزمنة.
    • على سبيل المثال، تُطوّر الشركات أجهزة قياس تنفس مدمجة وأجهزة محمولة لقياس وظائف الرئة تُوصل بالهواتف الذكية أو الأجهزة اللوحية، مما يُتيح للمرضى إجراء اختبارات دقيقة لوظائف الرئة من المنزل. وقد أظهرت أجهزة مثل جهاز MIR Spirobank Smart وجهاز NuvoAir Home Spirometer سهولة استخدام عالية ودقة تُضاهي الأجهزة المخبرية، مما يجعلها مناسبة للمراقبة الروتينية لحالات مثل مرض الانسداد الرئوي المزمن والربو.
  • تُعد هذه الابتكارات قيّمة بشكل خاص لإدارة أمراض الجهاز التنفسي المزمنة، إذ تُمكّن من التتبع المستمر لوظائف الرئة دون الحاجة إلى زيارات متكررة للمستشفى. ويُمكن للأطباء الوصول عن بُعد إلى بيانات المرضى عبر منصات سحابية، وتحديد العلامات المبكرة للتدهور، وتعديل خطط العلاج آنيًا، مما يُحسّن التزام المرضى بالعلاج ونتائجه.
  • يُحسّن دمج تقنية البلوتوث والاتصال السحابي في أنظمة PFT المحمولة مشاركة البيانات، والتوافق مع السجلات الصحية الإلكترونية (EHRs)، ويدعم التحليلات القائمة على الذكاء الاصطناعي لاتخاذ قرارات أكثر استنارة. يُسهم هذا في نهج أكثر ديناميكيةً وقائمةً على البيانات لرعاية الجهاز التنفسي في كلٍّ من البيئات الأولية والتخصصية.
  • مع تزايد توجه أنظمة الرعاية الصحية نحو نماذج الرعاية الوقائية والقائمة على القيمة، يتزايد الطلب على حلول فحص الرئة المحمولة وسهلة الاستخدام. ويستجيب المصنعون لهذا التوجه بإطلاق أجهزة وأنظمة برمجية تركز على الأجهزة المحمولة، تدعم التشخيص عن بُعد ومسارات رعاية الجهاز التنفسي الشخصية.

ديناميكيات سوق اختبار وظائف الرئة

سائق

"الحاجة المتزايدة نتيجةً لانتشار أمراض الجهاز التنفسي والتقدم التكنولوجي"

  • إن الانتشار المتزايد لأمراض الجهاز التنفسي مثل مرض الانسداد الرئوي المزمن (COPD) والربو وسرطان الرئة، إلى جانب التقدم التكنولوجي المستمر في أجهزة التشخيص، هو محرك مهم للطلب المتزايد على حلول اختبار وظائف الرئة (PFT).
    • على سبيل المثال، في أبريل 2024، استحوذت شركة كلاريو على شركة ArtiQ، وهي شركة متخصصة في تفسير اختبارات وظائف الرئة المدعومة بالذكاء الاصطناعي، مما عزز محفظة حلولها التنفسية من خلال دمج قدرات الذكاء الاصطناعي المتقدمة. ومن المتوقع أن تدفع هذه التطورات الاستراتيجية التي حققتها الشركات الرئيسية نمو قطاع اختبارات وظائف الرئة خلال الفترة المتوقعة.
  • مع تزايد وعي مقدمي الرعاية الصحية والمرضى بأهمية التشخيص المبكر والإدارة الفعالة لأمراض الرئة، توفر أجهزة PFT ميزات متقدمة لقياس دقيق لحجم الرئة وسعاتها وتدفق الهواء، مما يوفر رؤى حاسمة للتشخيص والعلاج
  • علاوة على ذلك، فإن الشعبية المتزايدة لأجهزة PFT المحمولة وسهلة الاستخدام، إلى جانب الرغبة في إمكانيات المراقبة عن بعد، تجعل من PFT جزءًا لا يتجزأ من رعاية الجهاز التنفسي الحديثة، مما يوفر تكاملاً سلسًا مع منصات الصحة الرقمية والسجلات الصحية الإلكترونية.
  • تُعدّ سهولة تقييم وظائف الرئة بدقة وبطريقة غير جراحية في مختلف البيئات، بما في ذلك المستشفيات والعيادات والرعاية المنزلية، عاملاً رئيسياً في دفع عجلة اعتماد اختبار وظائف الرئة. كما يُسهم التوجه نحو الطب الشخصي والتوافر المتزايد لخيارات اختبار وظائف الرئة المتقدمة في نمو السوق.

ضبط النفس/التحدي

" مخاوف بشأن ارتفاع التكاليف الأولية ونقص المتخصصين المهرة "

  • تشكل المخاوف المحيطة بالتكلفة الأولية المرتفعة لأنظمة اختبار وظائف الرئة المتقدمة ونقص المتخصصين المهرة المدربين على إجراء وتفسير هذه الاختبارات تحديًا كبيرًا لاختراق السوق على نطاق أوسع
    • على سبيل المثال، تتراوح أسعار أجهزة قياس التنفس الرقمية المتطورة وأنظمة قياس ضغط الدم بين 2000 و50000 دولار أمريكي ، مما يجعلها غير متاحة للعيادات الصغيرة ومقدمي الرعاية الصحية، لا سيما في المناطق منخفضة الدخل والنامية. إضافةً إلى ذلك، تواجه حوالي 35% من مرافق الرعاية الصحية في الاقتصادات النامية نقصًا في أطباء الرئة المدربين، مما يحد من انتشار استخدام أنظمة قياس ضغط الدم الرئوي.
  • إن معالجة تحديات التكلفة والخبرة من خلال تطوير أجهزة PFT أكثر تكلفةً وسهولةً في الاستخدام، إلى جانب مبادرات تدريب العاملين في مجال الرعاية الصحية، أمرٌ بالغ الأهمية لتعزيز انتشارها على نطاق أوسع. في حين أن أجهزة PFT الأساسية أصبحت أكثر تكلفةً، إلا أن الميزات المتقدمة، مثل الذكاء الاصطناعي المتكامل أو تحليل تبادل الغازات المتقدم، غالبًا ما تكون أعلى سعرًا.
  • في حين أن الأسعار تتناقص تدريجيًا، فإن القيمة المضافة المتوقعة لتقنية PFT المتقدمة لا تزال قادرة على إعاقة التبني على نطاق واسع، وخاصة بالنسبة لأولئك الذين لا يرون حاجة فورية للميزات الشاملة المقدمة
  • إن التغلب على هذه التحديات من خلال تحسين القدرة على تحمل التكاليف، وتثقيف المستهلكين حول فوائد التشخيص المبكر، وتطوير خيارات PFT الأكثر سهولة في الوصول إليها سيكون أمرًا حيويًا للنمو المستدام للسوق.

نطاق سوق اختبار وظائف الرئة

يتم تقسيم سوق اختبار وظائف الرئة العالمي على أساس النوع ونوع المريض والتطبيق والمستخدم النهائي.

  • حسب النوع

يُقسّم سوق اختبار وظائف الرئة، حسب نوعه، إلى أجهزة وخدمات وبرامج. وقد استحوذ قطاع الأجهزة على الحصة السوقية الأكبر في عام ٢٠٢٤، مدفوعًا بالحاجة الماسة إلى أجهزة مادية، مثل أجهزة قياس التنفس وأجهزة قياس ضغط الدم، لإجراء اختبارات وظائف الرئة. كما يُسهم الابتكار المستمر في الأجهزة المدمجة والمحمولة في هيمنته على السوق.

من المتوقع أن يسجل قطاع البرمجيات أعلى معدل نمو سنوي مركب، مدعومًا بالتكامل المتزايد للذكاء الاصطناعي وتحليلات البيانات والحلول المستندة إلى السحابة التي تعمل على تعزيز وظائف وتفسير وإدارة بيانات PFT.

  • حسب نوع المريض

بناءً على نوع المريض، يُقسّم سوق اختبارات وظائف الرئة إلى فئات: الأطفال، والبالغون، وكبار السن. استحوذت شريحة البالغين على الحصة الأكبر من السوق، نظرًا لتزايد انتشار العديد من أمراض الجهاز التنفسي المزمنة بشكل ملحوظ مع التقدم في السن، مما أدى إلى زيادة عدد اختبارات وظائف الرئة المُجراة على البالغين.

من المتوقع أن يشهد قطاع طب الشيخوخة نموًا سنويًا مركبًا ملحوظًا نظرًا لشيخوخة السكان عالميًا وزيادة قابلية كبار السن للإصابة بأمراض تنفسية مختلفة، مما يزيد الطلب على تقييمات وظائف الرئة الدورية. على سبيل المثال، في سوق اختبارات الرعاية المنزلية الأوسع نطاقًا

  • حسب الطلب

بناءً على التطبيق، يُقسّم سوق اختبار وظائف الرئة إلى مرض الانسداد الرئوي ومرض الانسداد الرئوي التقييدي. وقد هيمن قطاع مرض الانسداد الرئوي، الذي يعتمد بشكل رئيسي على حالات مثل مرض الانسداد الرئوي المزمن (COPD) والربو، على السوق بحصة سوقية تُقدر بنحو 39.8% في عام 2024. وتعود هذه الهيمنة إلى الانتشار العالمي المرتفع لهذه الحالات المزمنة، والدور المحوري لاختبار وظائف الرئة في تشخيصها وتقييم شدتها وإدارتها بشكل مستمر.

من المتوقع أن يشهد قطاع أمراض الانسداد الرئوي أسرع معدل نمو في الفترة من 2025 إلى 2032. ويعزى هذا النمو في المقام الأول إلى الانتشار المتزايد لمرض الانسداد الرئوي المزمن (COPD) والربو وأمراض الانسداد الأخرى، إلى جانب التقدم في تقنيات التشخيص.

  • حسب المستخدم النهائي

بناءً على المستخدم النهائي، يُقسّم سوق اختبار وظائف الرئة إلى مستشفيات، وعيادات متخصصة، ومختبرات تشخيصية، ومؤسسات رعاية منزلية، وغيرها. وقد استحوذ قطاع المستشفيات على أكبر حصة من إيرادات السوق، بنسبة 50.7% في عام 2024، بفضل قدراته التشخيصية الشاملة، وارتفاع عدد المرضى، وتوافر أجهزة اختبار وظائف الرئة المتطورة. وتُعدّ المستشفيات مراكز إحالة رئيسية لحالات الجهاز التنفسي المعقدة.

من المتوقع أن يشهد قطاع إعدادات الرعاية المنزلية أسرع معدل نمو، مدفوعًا بالتفضيل المتزايد لمراقبة المرضى عن بعد، والراحة في إدارة الأمراض المزمنة، والتوافر المتزايد لأجهزة PFT المحمولة المناسبة للاستخدام المنزلي.

تحليل إقليمي لسوق اختبار وظائف الرئة

  • تهيمن أمريكا الشمالية على سوق اختبار وظائف الرئة بأكبر حصة سوقية، بحصة سوقية تبلغ 38.9% في عام 2024، مدفوعة بانتشار واسع لأمراض الجهاز التنفسي، والبنية التحتية القوية للرعاية الصحية، والتبني المبكر للتقنيات الطبية المتقدمة.
  • يقدر المستهلكون ومقدمو الرعاية الصحية في المنطقة بشكل كبير الدقة والقدرات التشخيصية الشاملة والتكامل السلس الذي توفره أنظمة PFT الحديثة مع حلول الصحة الرقمية الأخرى
  • يتم دعم هذا التبني الواسع النطاق من خلال الإنفاق المرتفع على الرعاية الصحية، والمجتمع الطبي المتقدم من الناحية التكنولوجية، والوعي المتزايد بالتشخيص المبكر والرعاية الصحية الوقائية، مما يجعل اختبار وظائف الرئة الحل المفضل في المستشفيات والعيادات وحتى في أماكن الرعاية المنزلية.

نظرة عامة على سوق اختبار وظائف الرئة في الولايات المتحدة

استحوذ سوق اختبار وظائف الرئة في الولايات المتحدة على أكبر حصة من الإيرادات، بنسبة 76.3% في عام 2024. ويعزى هذا النمو إلى تزايد انتشار أمراض الجهاز التنفسي، وزيادة اعتماد تقنيات التشخيص المتقدمة، وتوسع البنية التحتية للرعاية الصحية. ويولي المستهلكون ومقدمو الرعاية الصحية أولوية متزايدة لتحسين مراقبة صحة الجهاز التنفسي من خلال أنظمة اختبار ذكية ودقيقة وسهلة الوصول. ويعزز الإقبال المتزايد على أجهزة اختبار وظائف الرئة المنزلية، إلى جانب الطلب القوي على المراقبة عن بُعد والتكامل الرقمي، نمو قطاع اختبار وظائف الرئة. علاوة على ذلك، يُسهم التكامل المتزايد لتقنيات الصحة الرقمية، مثل التفسير المعتمد على الذكاء الاصطناعي وإدارة البيانات السحابية، بشكل كبير في توسع السوق.

نظرة عامة على سوق اختبار وظائف الرئة في أوروبا

من المتوقع أن يشهد سوق اختبار وظائف الرئة في أوروبا نموًا ملحوظًا بمعدل نمو سنوي مركب خلال الفترة المتوقعة من 2025 إلى 2032، مدفوعًا بشكل رئيسي بتزايد انتشار أمراض الجهاز التنفسي، والتقدم التكنولوجي، والطلب المتزايد على الطب الشخصي. ويعزز ارتفاع نسبة كبار السن والوعي بصحة الرئة اعتماد اختبار وظائف الرئة. كما ينجذب المستهلكون الأوروبيون وأنظمة الرعاية الصحية إلى الدقة والرؤى الشاملة التي توفرها هذه الأجهزة. وتشهد المنطقة نموًا ملحوظًا في تطبيقات المستشفيات والعيادات التخصصية والرعاية المنزلية، حيث يتم دمج اختبار وظائف الرئة في بروتوكولات التشخيص المعمول بها ومبادرات الرعاية الصحية عن بُعد الناشئة.

نظرة عامة على سوق اختبار وظائف الرئة في المملكة المتحدة

من المتوقع أن ينمو سوق اختبار وظائف الرئة في المملكة المتحدة بمعدل نمو سنوي مركب ملحوظ خلال فترة التوقعات، مدفوعًا بالارتفاع المتسارع في انتشار أمراض الجهاز التنفسي والرغبة في زيادة دقة التشخيص وسهولة استخدامه. إضافةً إلى ذلك، تُشجع المخاوف المتعلقة بأمراض الرئة المزمنة والصحة العامة الأفراد ومقدمي الرعاية الصحية على اختيار حلول شاملة لتقييم وظائف الرئة. ومن المتوقع أن يواصل اعتماد المملكة المتحدة على الأجهزة الطبية المتقدمة، إلى جانب بنيتها التحتية المتينة للرعاية الصحية، تحفيز نمو السوق.

نظرة عامة على سوق اختبار وظائف الرئة في ألمانيا

من المتوقع أن يشهد سوق اختبار وظائف الرئة في ألمانيا نموًا ملحوظًا بمعدل نمو سنوي مركب خلال فترة التوقعات، مدفوعًا بتزايد الوعي بصحة الجهاز التنفسي والطلب على حلول دقيقة ومتطورة تقنيًا. وتعزز البنية التحتية المتطورة في ألمانيا، إلى جانب تركيزها على الابتكار ومعايير الرعاية الصحية العالية، اعتماد اختبار وظائف الرئة، لا سيما في المستشفيات ومختبرات التشخيص. كما يتزايد انتشار دمج اختبار وظائف الرئة مع أنظمة الصحة الرقمية، مع تفضيل كبير لحلول تشخيصية آمنة وموثوقة وعالية الجودة، تتوافق مع توقعات المستهلكين المحليين والقطاع الطبي.

نظرة عامة على سوق اختبار وظائف الرئة في منطقة آسيا والمحيط الهادئ

من المتوقع أن يشهد سوق اختبار وظائف الرئة في منطقة آسيا والمحيط الهادئ نموًا بمعدل نمو سنوي مركب يبلغ 7.7% بين عامي 2025 و2032 ، مدفوعًا بالتوسع الحضري المتزايد، وارتفاع الدخل المتاح، والتقدم التكنولوجي في دول مثل الصين واليابان والهند. ويساهم التوجه المتزايد في المنطقة نحو تحسين البنية التحتية للرعاية الصحية، بدعم من المبادرات الحكومية الرامية إلى تعزيز الصحة العامة، في تعزيز اعتماد اختبار وظائف الرئة. علاوة على ذلك، ومع بروز منطقة آسيا والمحيط الهادئ كمركز تصنيع لمكونات وأنظمة اختبار وظائف الرئة، تتوسع إمكانية الوصول إلى حلول اختبار وظائف الرئة وبأسعار معقولة لتشمل قاعدة أوسع من المستهلكين.

نظرة عامة على سوق اختبار وظائف الرئة في اليابان

يشهد سوق اختبار وظائف الرئة في اليابان زخمًا متزايدًا بفضل ثقافة التكنولوجيا المتقدمة في البلاد، والتوسع الحضري السريع، والطلب على الرعاية الصحية المتقدمة. ويولي السوق الياباني اهتمامًا كبيرًا بالتشخيص المبكر والمراقبة الدقيقة لأمراض الجهاز التنفسي، ويعزى اعتماد اختبار وظائف الرئة إلى تزايد عدد مرضى أمراض الرئة المزمنة ودمجه مع السجلات الصحية الرقمية. وأفادت وزارة الصحة والعمل والرعاية الاجتماعية بأن نسبة اعتماد مقياس التنفس الرقمي في المستشفيات اليابانية ارتفعت من 45% عام 2021 إلى 72% عام 2023، مع توقعات بأن تصل إلى 85% بحلول عام 2024. علاوة على ذلك، من المرجح أن يؤدي شيخوخة السكان في اليابان إلى زيادة الطلب على حلول تشخيصية سهلة الاستخدام ودقيقة في كل من البيئات السريرية والمنزلية.

نظرة عامة على سوق اختبار وظائف الرئة في الهند

من المتوقع أن يشهد سوق اختبار وظائف الرئة في الهند أعلى معدل نمو سنوي مركب قدره 7.8% بين عامي 2025 و2032 ، مدفوعًا بارتفاع معدل انتشار أمراض الجهاز التنفسي، وارتفاع مستويات تلوث الهواء، وتنامي الوعي بصحة الجهاز التنفسي. ويؤدي توسع البنية التحتية للرعاية الصحية في البلاد، إلى جانب المبادرات الحكومية لمكافحة أمراض الجهاز التنفسي، إلى زيادة اعتماد حلول اختبار وظائف الرئة. كما يستفيد السوق من الطلب المتزايد على أدوات التشخيص المحمولة والفعّالة من حيث التكلفة، مما يجعل اختبار وظائف الرئة في متناول شريحة أكبر من السكان.

حصة سوق اختبار وظائف الرئة

وتقود صناعة اختبار وظائف الرئة في المقام الأول شركات راسخة، بما في ذلك:

  • شركة زول الطبية (الولايات المتحدة)
  • شركة تليفليكس المحدودة (الولايات المتحدة)
  • شركة القاهرة (الولايات المتحدة)
  • شركة COSMED srl (إيطاليا)
  • شركة شيلر إيه جي (سويسرا)
  • شركة GANSHORN Medizin Electronic GmbH (ألمانيا)
  • شركة بولم ون للأجهزة الطبية المتقدمة (إسرائيل)
  • ndd Medical Technologies (سويسرا)
  • كوكو PFT (المملكة المتحدة)
  • شركة جيراثيرم الطبية (ألمانيا)
  • شركة إيكو ميديكس إيه جي (سويسرا)
  • مورغان ساينتيفيك (الولايات المتحدة)
  • سيبل، ساو (إسبانيا)
  • كلاريتي ميديكال (الهند)
  • علوم البيانات الدولية (الولايات المتحدة)
  • إنجمار الطبية (الولايات المتحدة)
  • نظام جيه كي الطبي (الهند)
  • شركة MEC المحدودة (المملكة المتحدة)
  • ميدلاين إندستريز، إل بي (الولايات المتحدة)
  • المسجلات وأنظمة الرعاية الطبية (الهند)
  • فيتالوغراف (أيرلندا)
  • المعدات الطبية أوروبا GMBH (ألمانيا)
  • شركة تشيست مي (اليابان)
  • شركة كونتيك للأنظمة الطبية المحدودة (الصين)
  • فوكودا دينشي (اليابان)

أحدث التطورات في سوق اختبار وظائف الرئة العالمي

  • في أبريل 2024، أعلنت شركة كلاريو، الرائدة في توفير حلول التجارب السريرية، عن استحواذها على شركة أرتيك، وهي شركة متخصصة في تفسير اختبارات وظائف الرئة (PFT) باستخدام الذكاء الاصطناعي. تهدف هذه الخطوة الاستراتيجية إلى تعزيز محفظة حلول كلاريو التنفسية من خلال دمج قدرات الذكاء الاصطناعي المتقدمة، مما يؤكد التوجه المتزايد نحو الاستفادة من الذكاء الاصطناعي لتحليل اختبارات وظائف الرئة (PFT) بدقة وكفاءة أعلى. يُبرز هذا التطور التزام القطاع بتحسين القدرات التشخيصية في مجال رعاية الجهاز التنفسي.
  • في سبتمبر 2023، أطلقت شركة PulmOne، المطورة لأجهزة اختبار وظائف الرئة المحمولة، جهاز MiniBox+ في الصين. وعُرض الجهاز على أطباء أمراض الرئة في المؤتمر السنوي للجمعية الصينية لأمراض الصدر (CTS) لعام 2023 من خلال موزعها HTDK. ويشير هذا الإطلاق إلى تزايد التركيز على حلول اختبار وظائف الرئة المحمولة وسهلة الاستخدام، لا سيما في الأسواق سريعة النمو مثل الصين، لتلبية الطلب المتزايد على أجهزة مراقبة وظائف الرئة بسهولة.
  • في مايو 2023، وسّعت شركة فيتالوغراف، الرائدة في مجال تشخيصات الجهاز التنفسي، محفظة منتجاتها بإطلاق جهاز قياس الذبذبات فيتالوغراف تريموفلو سي-100 في مؤتمر ATS الدولي. يُبرز هذا الجهاز الجديد التحوّل نحو أساليب الاختبار المتقدمة غير الجراحية، مثل قياس الذبذبات، الذي يُوفّر معلومات مُحدّدة حول وظيفة مجرى الهواء الصغير دون الحاجة إلى مناورات قسرية، مما يجعله مثاليًا لمجموعة أوسع من المرضى، بمن فيهم الأطفال. 
  • في أبريل 2023، أطلقت شركة IngMar Medical، المتخصصة في تقنيات محاكاة الجهاز التنفسي، الإصدار 4.3 من برنامج RespiSim. يتضمن هذا التطور الرئيسي تحسينًا في استيراد وتصدير السيناريوهات، وتقليل تأخر المحاكاة، وتعزيز استقرار المنصة. تُحسّن هذه التحديثات بشكل كبير من سهولة الاستخدام والأداء، مما يجعلها أداةً حيويةً لتعليم وتدريب العلاج التنفسي، مما يُسهم في فهم وتطبيق مبادئ PFT بشكل أفضل. 
  • في يناير 2023، استحوذت شركة CAIRE Inc. على شركة MGC Diagnostics Holdings, Inc.، في خطوة استراتيجية تهدف إلى الاستفادة من شبكة التوزيع العالمية الواسعة لشركة MGC وتواجدها التصنيعي الواسع. يُعزز هذا الاستحواذ وصول المرضى إلى أنظمة MGC التشخيصية القلبية التنفسية المتقدمة، بما في ذلك أجهزة اختبار وظائف الرئة (PFT)، ويعكس جهود التوحيد والشراكات الاستراتيجية المستمرة في السوق لتوسيع نطاق الوصول وعروض المنتجات.

SKU-

احصل على إمكانية الوصول عبر الإنترنت إلى التقرير الخاص بأول سحابة استخبارات سوقية في العالم

  • لوحة معلومات تحليل البيانات التفاعلية
  • لوحة معلومات تحليل الشركة للفرص ذات إمكانات النمو العالية
  • إمكانية وصول محلل الأبحاث للتخصيص والاستعلامات
  • تحليل المنافسين باستخدام لوحة معلومات تفاعلية
  • آخر الأخبار والتحديثات وتحليل الاتجاهات
  • استغل قوة تحليل المعايير لتتبع المنافسين بشكل شامل
طلب التجريبي

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE GLOBAL PULMONARY FUNCTION TESTING MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 MARKET APPLICATION COVERAGE GRID

2.8 PRODUCT LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PORTER’S FIVE FORCES

4.2 PESTEL ANALYSIS

5 REGULATORY FRAMEWORK

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING PREVALENCE OF RESPIRATORY DISEASES

6.1.2 EARLY DETECTION OF RESPIRATORY DISEASES

6.1.3 GROWING GERIATRIC POPULATION

6.1.4 INCREASING PRODUCT LAUNCHES AND EMERGENCE OF HOME TESTING DEVICES

6.2 RESTRAINTS

6.2.1 HIGH COST OF TESTING EQUIPMENT

6.2.2 TECHNOLOGICAL LIMITATION OF TESTING DEVICES

6.3 OPPORTUNITIES

6.3.1 RAPID TECHNOLOGICAL ADVANCEMENTS

6.3.2 RISING STRATEGIC INITIATIVES

6.3.3 GOVERNMENT INITIATIVES AND REIMBURSEMENT POLICIES

6.3.4 PRODUCT DEVELOPMENT FOR AT-HOME TESTING

6.4 CHALLENGES

6.4.1 LACK OF STANDARDIZATION AND VARIABILITY IN TEST RESULTS

6.4.2 LACK OF SKILLED PROFESSIONALS

7 GLOBAL PULMONARY FUNCTION TESTING MARKET, BY TYPE

7.1 OVERVIEW

7.2 HARDWARE

7.2.1 PFT DEVICES

7.2.2 PFT ACCESSORIES & CONSUMABLES

7.2.2.1 SPIROMETRY

7.2.2.2 LUNG VOLUME IN UNIT/ PLETHYSMOGRAPHY TEST

7.2.2.3 GAS EXCHANGE TESTING

7.2.2.4 CARDIOPULMONARY EXERCISE TEST (CPET)

7.2.2.5 PULSE OXIMETRY TEST

7.2.2.6 DIFFUSION CAPACITY TEST

7.2.2.7 MAXIMAL VOLUNTARY VENTILATION

7.2.2.8 OXYGEN TITRATION TEST

7.2.2.9 RESPIRATORY MUSCLE FUNCTION

7.2.2.10 BRONCHIAL PROVOCATION TEST

7.2.2.11 HIGH ALTITUDE SIMULATION TESTING

7.2.3 OTHERS

7.2.3.1 3.2. DIRECT TENDER

7.2.3.2 3.2. RETAIL SALES

7.2.4 OTHERS

7.3 SOFTWARE

7.4 SERVICES

8 GLOBAL PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE

8.1 OVERVIEW

8.2 ADULT

8.2.1 MALE

8.2.2 FEMALE

8.3 GERIATRIC

8.3.1 MALE

8.3.2 FEMALE

8.4 PEDIATRIC

8.4.1 MALE

8.4.2 FEMALE

9 GLOBAL PULMONARY FUNCTION TESTING MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 OBSTRUCTIVE LUNG DISEASE

9.2.1 ASTHMA

9.2.2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

9.2.3 BRONCHIECTASIS

9.2.4 CYSTIC FIBROSIS

9.3 RESTRICTIVE LUNG DISEASE

9.3.1 LUNG CANCER

9.3.2 INTERSTITIAL LUNG DISEASE

9.3.3 AMYOTROPHIC LATERAL SCLEROSIS (ALS)

9.3.4 SCOLIOSIS

9.3.5 SARCOIDOSIS

9.3.6 MUSCULAR DYSTROPHY

10 GLOBAL PULMONARY FUNCTION TESTING MARKET, BY END USER

10.1 OVERVIEW

10.2 HOSPITALS

10.2.1 PUBLIC

10.2.2 PRIVATE

10.3 SPECIALTY CLINICS

10.4 DIAGNOSTICS LABORATORIES

10.5 HOME CARE SETTINGS

10.6 OTHERS

11 GLOBAL PULMONARY FUNCTION TESTING MARKET, BY REGION

11.1 OVERVIEW

11.2 NORTH AMERICA

11.2.1 U.S.

11.2.2 CANADA

11.2.3 MEXICO

11.3 EUROPE

11.3.1 GERMANY

11.3.2 U.K.

11.3.3 FRANCE

11.3.4 FRANCE

11.3.5 ITALY

11.3.6 TURKEY

11.3.7 RUSSIA

11.3.8 SWITZERLAND

11.3.9 NETHERLANDS

11.3.10 SWEDEN

11.3.11 BELGIUM

11.3.12 DENMARK

11.3.13 NORWAY

11.3.14 FINLAND

11.3.15 POLAND

11.3.16 REST OF EUROPE

11.4 ASIA-PACIFIC

11.4.1 JAPAN

11.4.2 CHINA

11.4.3 SOUTH KOREA

11.4.4 INDIA

11.4.5 AUSTRALIA

11.4.6 SINGAPORE

11.4.7 TAIWAN

11.4.8 THAILAND

11.4.9 MALAYSIA

11.4.10 NEW ZEALAND

11.4.11 INDONESIA

11.4.12 VIETNAM

11.4.13 PHILIPPINES

11.4.14 REST OF ASIA-PACIFIC

11.5 MIDDLE EAST AND AFRICA

11.5.1 SOUTH AFRICA

11.5.2 SAUDI ARABIA

11.5.3 U.A.E.

11.5.4 ISRAEL

11.5.5 QATAR

11.5.6 KUWAIT

11.5.7 EGYPT

11.5.8 OMAN

11.5.9 BAHRAIN

11.5.10 REST OF MIDDLE EAST AND AFRICA

11.6 SOUTH AMERICA

11.6.1 BRAZIL

11.6.2 ARGENTINA

11.6.3 REST OF SOUTH AMERICA

12 GLOBAL PULMONARY FUNCTION TESTING MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: GLOBAL

12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

12.3 COMPANY SHARE ANALYSIS: EUROPE

12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

13 SWOT ANALYSIS

14 COMPANY PROFILES

14.1 VYAIRE MEDICAL, INC.

14.1.1 COMPANY SNAPSHOT

14.1.2 COMPANY SHARE ANALYSIS

14.1.3 PRODUCT PORTFOLIO

14.1.4 RECENT DEVELOPMENTS

14.2 TELEFLEX INCORPORATED

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 COMPANY SHARE ANALYSIS

14.2.4 PRODUCT PORTFOLIO 488

14.2.5 RECENT DEVELOPMENT 488

14.3 CAIRE INC.

14.3.1 COMPANY SNAPSHOT

14.3.2 COMPANY SHARE ANALYSIS

14.3.3 PRODUCT PORTFOLIO

14.3.4 RECENT DEVELOPMENTS

14.4 COSMED SRL

14.4.1 COMPANY SNAPSHOT

14.4.2 COMPANY SHARE ANALYSIS

14.4.3 PRODUCT PORTFOLIO

14.4.4 RECENT DEVELOPMENTS

14.5 SCHILLER AG

14.5.1 COMPANY SNAPSHOT

14.5.2 COMPANY SHARE ANALYSIS

14.5.3 PRODUCT PORTFOLIO

14.5.4 RECENT DEVELOPMENTS

14.6 CHEST M.I., INC.

14.6.1 COMPANY SNAPSHOT

14.6.2 PRODUCT PORTFOLIO

14.6.3 RECENT DEVELOPMENTS

14.7 CLARITY MEDICAL

14.7.1 COMPANY SNAPSHOT

14.7.2 PRODUCT PORTFOLIO

14.7.3 RECENT DEVELOPMENT

14.8 CONTEC MEDICAL SYSTEMS CO., LTD

14.8.1 COMPANY SNAPSHOT

14.8.2 PRODUCT PORTFOLIO

14.8.3 RECENT DEVELOPMENT

14.9 DATA SCIENCES INTERNATIONAL.

14.9.1 COMPANY SNAPSHOT

14.9.2 PRODUCT PORTFOLIO

14.9.3 RECENT DEVELOPMENTS

14.1 ECO MEDICS

14.10.1 COMPANY SNAPSHOT

14.10.2 PRODUCT PORTFOLIO

14.10.3 RECENT DEVELOPMENTS

14.11 FUKUDA SANGYO CO., LTD.

14.11.1 COMPANY SNAPSHOT

14.11.2 PRODUCT PORTFOLIO

14.11.3 RECENT DEVELOPMENT

14.12 GANSHORN MEDIZIN ELECTRONIC GMBH

14.12.1 COMPANY SNAPSHOT

14.12.2 PRODUCT PORTFOLIO

14.12.3 RECENT DEVELOPMENTS

14.13 GERATHERM MEDICAL AG

14.13.1 COMPANY SNAPSHOT

14.13.2 REVENUE ANALYSIS

14.13.3 PRODUCT PORTFOLIO

14.13.4 RECENT DEVELOPMENT

14.14 INGMAR MEDICAL

14.14.1 COMPANY SNAPSHOT

14.14.2 PRODUCT PORTFOLIO

14.14.3 RECENT DEVELOPMENT

14.15 INOFAB HEALTH (A CLARIO COMPANY)

14.15.1 COMPANY SNAPSHOT

14.15.2 PRODUCT PORTFOLIO

14.15.3 RECENT DEVELOPMENT

14.16 JK MEDICAL SYSTEMS PVT LTD.

14.16.1 COMPANY SNAPSHOT

14.16.2 PRODUCT PORTFOLIO

14.16.3 RECENT DEVELOPMENTS

14.17 KOKO, PFT

14.17.1 COMPANY SNAPSHOT

14.17.2 PRODUCT PORTFOLIO

14.17.3 RECENT DEVELOPMENTS

14.18 MEC

14.18.1 COMPANY SNAPSHOT

14.18.2 PRODUCT PORTFOLIO

14.18.3 RECENT DEVELOPMENT

14.19 MEDICAL EQUIPMENT EUROPE GMBH

14.19.1 COMPANY SNAPSHOT

14.19.2 PRODUCT PORTFOLIO

14.19.3 RECENT DEVELOPMENTS

14.2 MEDLINE

14.20.1 COMPANY SNAPSHOT

14.20.2 PRODUCT PORTFOLIO

14.20.3 RECENT DEVELOPMENT

14.21 MORGAN SCIENTIFIC

14.21.1 COMPANY SNAPSHOT

14.21.2 PRODUCT PORTFOLIO

14.21.3 RECENT DEVELOPMENTS

14.22 NDD MEDICAL TECHNOLOGIES

14.22.1 COMPANY SNAPSHOT

14.22.2 PRODUCT PORTFOLIO

14.22.3 RECENT DEVELOPMENTS

14.23 PULMONE ADVANCED MEDICAL DEVICES

14.23.1 COMPANY SNAPSHOT

14.23.2 PRODUCT PORTFOLIO

14.23.3 RECENT DEVELOPMENT

14.24 RECORDERS & MEDICARE SYSTEMS PRIVATE LIMITED

14.24.1 COMPANY SNAPSHOT

14.24.2 PRODUCT PORTFOLIO

14.24.3 RECENT DEVELOPMENT

14.25 SCIREQ

14.25.1 COMPANY SNAPSHOT

14.25.2 PRODUCT PORTFOLIO

14.25.3 RECENT DEVELOPMENT

14.26 SIBEL, S.A.U

14.26.1 COMPANY SNAPSHOT

14.26.2 PRODUCT PORTFOLIO

14.26.3 RECENT DEVELOPMENT

14.27 VITALOGRAPH

14.27.1 COMPANY SNAPSHOT

14.27.2 PRODUCT PORTFOLIO

14.27.3 RECENT DEVELOPMENT

15 QUESTIONNAIRE

16 RELATED REPORTS

List of Table

TABLE 1 GLOBAL DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 2 GLOBAL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 3 GLOBAL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 4 GLOBAL PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 5 GLOBAL PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (VOLUME IN UNIT)

TABLE 6 GLOBAL PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 7 GLOBAL PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 8 GLOBAL PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (VOLUME IN UNIT)

TABLE 9 GLOBAL MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 10 GLOBAL ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 11 GLOBAL NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 12 GLOBAL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 13 GLOBAL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 14 GLOBAL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 15 GLOBAL SOFTWARE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 16 GLOBAL SERVICES IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 17 GLOBAL PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 18 GLOBAL ADULT IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 19 GLOBAL ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 20 GLOBAL GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 21 GLOBAL GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 22 GLOBAL PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 23 GLOBAL PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 24 GLOBAL PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 25 GLOBAL OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 26 GLOBAL OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 27 GLOBAL RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 28 GLOBAL RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 29 GLOBAL PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 30 GLOBAL HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 31 GLOBAL HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 32 GLOBAL SPECIALTY CLINICS IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 33 GLOBAL DIAGNOSTICS LABORATORIES IN PULMONARY FUNCTION TESTING, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 34 GLOBAL HOME CARE SETTINGS IN PULMONARY FUNCTION TESTING, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 35 GLOBAL OTHERS IN PULMONARY FUNCTION TESTING, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 36 GLOBAL PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)

TABLE 37 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)

TABLE 38 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 39 NORTH AMERICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 40 NORTH AMERICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 41 NORTH AMERICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 42 NORTH AMERICA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 43 NORTH AMERICA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 44 NORTH AMERICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 45 NORTH AMERICA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 46 NORTH AMERICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 47 NORTH AMERICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 48 NORTH AMERICA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 49 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 50 NORTH AMERICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 51 NORTH AMERICA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 52 NORTH AMERICA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 53 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 54 NORTH AMERICA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 55 NORTH AMERICA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 56 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 57 NORTH AMERICA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 58 U.S. PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 59 U.S. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 60 U.S. PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 61 U.S. PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 62 U.S. PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 63 U.S. MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 64 U.S. ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 65 U.S. NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 66 U.S. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 67 U.S. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 68 U.S. RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 69 U.S. PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 70 U.S. ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 71 U.S. GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 72 U.S. PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 73 U.S. PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 74 U.S. OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 75 U.S. RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 76 U.S. PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 77 U.S. HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 78 CANADA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 79 CANADA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 80 CANADA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 81 CANADA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 82 CANADA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 83 CANADA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 84 CANADA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 85 CANADA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 86 CANADA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 87 CANADA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 88 CANADA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 89 CANADA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 90 CANADA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 91 CANADA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 92 CANADA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 93 CANADA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 94 CANADA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 95 CANADA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 96 CANADA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 97 CANADA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 98 MEXICO PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 99 MEXICO HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 100 MEXICO PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 101 MEXICO PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 102 MEXICO PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 103 MEXICO MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 104 MEXICO ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 105 MEXICO NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 106 MEXICO HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 107 MEXICO HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 108 MEXICO RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 109 MEXICO PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 110 MEXICO ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 111 MEXICO GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 112 MEXICO PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 113 MEXICO PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 114 MEXICO OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 115 MEXICO RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 116 MEXICO PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 117 MEXICO HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 118 EUROPE PULMONARY FUNCTION TESTING MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)

TABLE 119 EUROPE PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 120 EUROPE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 121 EUROPE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 122 EUROPE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 123 EUROPE PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 124 EUROPE MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 125 EUROPE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 126 EUROPE NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 127 EUROPE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 128 EUROPE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 129 EUROPE RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 130 EUROPE PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 131 EUROPE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 132 EUROPE GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 133 EUROPE PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 134 EUROPE PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 135 EUROPE OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 136 EUROPE RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 137 EUROPE PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 138 EUROPE HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 139 GERMANY PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 140 GERMANY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 141 GERMANY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 142 GERMANY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 143 GERMANY PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 144 GERMANY MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 145 GERMANY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 146 GERMANY NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 147 GERMANY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 148 GERMANY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 149 GERMANY RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 150 GERMANY PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 151 GERMANY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 152 GERMANY GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 153 GERMANY PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 154 GERMANY PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 155 GERMANY OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 156 GERMANY RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 157 GERMANY PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 158 GERMANY HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 159 U.K. PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 160 U.K. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 161 U.K. PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 162 U.K. PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 163 U.K. PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 164 U.K. MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 165 U.K. ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 166 U.K. NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 167 U.K. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 168 U.K. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 169 U.K. RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 170 U.K. PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 171 U.K. ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 172 U.K. GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 173 U.K. PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 174 U.K. PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 175 U.K. OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 176 U.K. RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 177 U.K. PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 178 U.K. HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 179 FRANCE PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 180 FRANCE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 181 FRANCE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 182 FRANCE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 183 FRANCE PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 184 FRANCE MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 185 FRANCE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 186 FRANCE NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 187 FRANCE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 188 FRANCE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 189 FRANCE RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 190 FRANCE PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 191 FRANCE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 192 FRANCE GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 193 FRANCE PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 194 FRANCE PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 195 FRANCE OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 196 FRANCE RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 197 FRANCE PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 198 FRANCE HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 199 SPAIN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 200 SPAIN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 201 SPAIN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 202 SPAIN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 203 SPAIN PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 204 SPAIN MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 205 SPAIN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 206 SPAIN NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 207 SPAIN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 208 SPAIN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 209 SPAIN RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 210 SPAIN PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 211 SPAIN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 212 SPAIN GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 213 SPAIN PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 214 SPAIN PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 215 SPAIN OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 216 SPAIN RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 217 SPAIN PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 218 SPAIN HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 219 ITALY PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 220 ITALY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 221 ITALY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 222 ITALY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 223 ITALY PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 224 ITALY MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 225 ITALY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 226 ITALY NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 227 ITALY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 228 ITALY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 229 ITALY RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 230 ITALY PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 231 ITALY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 232 ITALY GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 233 ITALY PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 234 ITALY PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 235 ITALY OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 236 ITALY RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 237 ITALY PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 238 ITALY HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 239 TURKEY PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 240 TURKEY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 241 TURKEY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 242 TURKEY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 243 TURKEY PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 244 TURKEY MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 245 TURKEY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 246 TURKEY NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 247 TURKEY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 248 TURKEY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 249 TURKEY RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 250 TURKEY PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 251 TURKEY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 252 TURKEY GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 253 TURKEY PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 254 TURKEY PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 255 TURKEY OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 256 TURKEY RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 257 TURKEY PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 258 TURKEY HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 259 RUSSIA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 260 RUSSIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 261 RUSSIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 262 RUSSIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 263 RUSSIA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 264 RUSSIA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 265 RUSSIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 266 RUSSIA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 267 RUSSIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 268 RUSSIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 269 RUSSIA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 270 RUSSIA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 271 RUSSIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 272 RUSSIA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 273 RUSSIA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 274 RUSSIA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 275 RUSSIA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 276 RUSSIA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 277 RUSSIA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 278 RUSSIA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 279 SWITZERLAND PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 280 SWITZERLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 281 SWITZERLAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 282 SWITZERLAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 283 SWITZERLAND PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 284 SWITZERLAND MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 285 SWITZERLAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 286 SWITZERLAND NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 287 SWITZERLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 288 SWITZERLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 289 SWITZERLAND RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 290 SWITZERLAND PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 291 SWITZERLAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 292 SWITZERLAND GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 293 SWITZERLAND PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 294 SWITZERLAND PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 295 SWITZERLAND OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 296 SWITZERLAND RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 297 SWITZERLAND PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 298 SWITZERLAND HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 299 NETHERLANDS PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 300 NETHERLANDS HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 301 NETHERLANDS PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 302 NETHERLANDS PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 303 NETHERLANDS PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 304 NETHERLANDS MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 305 NETHERLANDS ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 306 NETHERLANDS NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 307 NETHERLANDS HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 308 NETHERLANDS HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 309 NETHERLANDS RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 310 NETHERLANDS PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 311 NETHERLANDS ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 312 NETHERLANDS GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 313 NETHERLANDS PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 314 NETHERLANDS PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 315 NETHERLANDS OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 316 NETHERLANDS RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 317 NETHERLANDS PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 318 NETHERLANDS HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 319 SWEDEN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 320 SWEDEN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 321 SWEDEN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 322 SWEDEN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 323 SWEDEN PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 324 SWEDEN MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 325 SWEDEN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 326 SWEDEN NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 327 SWEDEN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 328 SWEDEN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 329 SWEDEN RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 330 SWEDEN PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 331 SWEDEN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 332 SWEDEN GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 333 SWEDEN PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 334 SWEDEN PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 335 SWEDEN OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 336 SWEDEN RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 337 SWEDEN PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 338 SWEDEN HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 339 BELGIUM PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 340 BELGIUM HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 341 BELGIUM PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 342 BELGIUM PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 343 BELGIUM PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 344 BELGIUM MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 345 BELGIUM ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 346 BELGIUM NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 347 BELGIUM HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 348 BELGIUM HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 349 BELGIUM RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 350 BELGIUM PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 351 BELGIUM ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 352 BELGIUM GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 353 BELGIUM PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 354 BELGIUM PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 355 BELGIUM OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 356 BELGIUM RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 357 BELGIUM PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 358 BELGIUM HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 359 DENMARK PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 360 DENMARK HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 361 DENMARK PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 362 DENMARK PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 363 DENMARK PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 364 DENMARK MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 365 DENMARK ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 366 DENMARK NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 367 DENMARK HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 368 DENMARK HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 369 DENMARK RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 370 DENMARK PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 371 DENMARK ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 372 DENMARK GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 373 DENMARK PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 374 DENMARK PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 375 DENMARK OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 376 DENMARK RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 377 DENMARK PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 378 DENMARK HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 379 NORWAY PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 380 NORWAY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 381 NORWAY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 382 NORWAY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 383 NORWAY PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 384 NORWAY MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 385 NORWAY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 386 NORWAY NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 387 NORWAY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 388 NORWAY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 389 NORWAY RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 390 NORWAY PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 391 NORWAY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 392 NORWAY GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 393 NORWAY PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 394 NORWAY PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 395 NORWAY OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 396 NORWAY RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 397 NORWAY PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 398 NORWAY HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 399 FINLAND PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 400 FINLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 401 FINLAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 402 FINLAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 403 FINLAND PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 404 FINLAND MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 405 FINLAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 406 FINLAND NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 407 FINLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 408 FINLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 409 FINLAND RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 410 FINLAND PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 411 FINLAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 412 FINLAND GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 413 FINLAND PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 414 FINLAND PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 415 FINLAND OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 416 FINLAND RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 417 FINLAND PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 418 FINLAND HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 419 POLAND PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 420 POLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 421 POLAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 422 POLAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 423 POLAND PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 424 POLAND MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 425 POLAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 426 POLAND NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 427 POLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 428 POLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 429 POLAND RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 430 POLAND PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 431 POLAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 432 POLAND GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 433 POLAND PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 434 POLAND PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 435 POLAND OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 436 POLAND RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 437 POLAND PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 438 POLAND HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 439 REST OF EUROPE PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 440 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)

TABLE 441 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 442 ASIA-PACIFIC HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 443 ASIA-PACIFIC PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 444 ASIA-PACIFIC PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 445 ASIA-PACIFIC PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 446 ASIA-PACIFIC MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 447 ASIA-PACIFIC ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 448 ASIA-PACIFIC NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 449 ASIA-PACIFIC HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 450 ASIA-PACIFIC HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 451 ASIA-PACIFIC RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 452 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 453 ASIA-PACIFIC ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 454 ASIA-PACIFIC GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 455 ASIA-PACIFIC PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 456 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 457 ASIA-PACIFIC OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 458 ASIA-PACIFIC RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 459 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 460 ASIA-PACIFIC HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 461 JAPAN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 462 JAPAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 463 JAPAN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 464 JAPAN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 465 JAPAN PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 466 JAPAN MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 467 JAPAN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 468 JAPAN NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 469 JAPAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 470 JAPAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 471 JAPAN RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 472 JAPAN PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 473 JAPAN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 474 JAPAN GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 475 JAPAN PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 476 JAPAN PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 477 JAPAN OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 478 JAPAN RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 479 JAPAN PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 480 JAPAN HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 481 CHINA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 482 CHINA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 483 CHINA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 484 CHINA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 485 CHINA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 486 CHINA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 487 CHINA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 488 CHINA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 489 CHINA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 490 CHINA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 491 CHINA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 492 CHINA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 493 CHINA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 494 CHINA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 495 CHINA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 496 CHINA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 497 CHINA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 498 CHINA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 499 CHINA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 500 CHINA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 501 SOUTH KOREA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 502 SOUTH KOREA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 503 SOUTH KOREA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 504 SOUTH KOREA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 505 SOUTH KOREA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 506 SOUTH KOREA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 507 SOUTH KOREA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 508 SOUTH KOREA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 509 SOUTH KOREA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 510 SOUTH KOREA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 511 SOUTH KOREA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 512 SOUTH KOREA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 513 SOUTH KOREA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 514 SOUTH KOREA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 515 SOUTH KOREA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 516 SOUTH KOREA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 517 SOUTH KOREA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 518 SOUTH KOREA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 519 SOUTH KOREA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 520 SOUTH KOREA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 521 INDIA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 522 INDIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 523 INDIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 524 INDIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 525 INDIA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 526 INDIA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 527 INDIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 528 INDIA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 529 INDIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 530 INDIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 531 INDIA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 532 INDIA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 533 INDIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 534 INDIA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 535 INDIA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 536 INDIA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 537 INDIA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 538 INDIA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 539 INDIA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 540 INDIA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 541 AUSTRALIA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 542 AUSTRALIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 543 AUSTRALIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 544 AUSTRALIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 545 AUSTRALIA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 546 AUSTRALIA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 547 AUSTRALIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 548 AUSTRALIA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 549 AUSTRALIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 550 AUSTRALIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 551 AUSTRALIA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 552 AUSTRALIA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 553 AUSTRALIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 554 USTRALIA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 555 AUSTRALIA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 556 AUSTRALIA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 557 AUSTRALIA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 558 AUSTRALIA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 559 AUSTRALIA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 560 AUSTRALIA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 561 SINGAPORE PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 562 SINGAPORE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 563 SINGAPORE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 564 SINGAPORE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 565 SINGAPORE PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 566 SINGAPORE MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 567 SINGAPORE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 568 SINGAPORE NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 569 SINGAPORE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 570 SINGAPORE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 571 SINGAPORE RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 572 SINGAPORE PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 573 SINGAPORE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 574 SINGAPORE GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 575 SINGAPORE PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 576 SINGAPORE PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 577 SINGAPORE OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 578 SINGAPORE RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 579 SINGAPORE PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 580 SINGAPORE HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 581 TAIWAN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 582 TAIWAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 583 TAIWAN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 584 TAIWAN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 585 TAIWAN PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 586 TAIWAN MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 587 TAIWAN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 588 TAIWAN NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 589 TAIWAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 590 TAIWAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 591 TAIWAN RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 592 TAIWAN PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 593 TAIWAN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 594 TAIWAN GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 595 TAIWAN PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 596 TAIWAN PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 597 TAIWAN OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 598 TAIWAN RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 599 TAIWAN PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 600 TAIWAN HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 601 THAILAND PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 602 THAILAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 603 THAILAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 604 THAILAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 605 THAILAND PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 606 THAILAND MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 607 THAILAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 608 THAILAND NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 609 THAILAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 610 THAILAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 611 THAILAND RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 612 THAILAND PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 613 THAILAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 614 THAILAND GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 615 THAILAND PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 616 THAILAND PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 617 THAILAND OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 618 THAILAND RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 619 THAILAND PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 620 THAILAND HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 621 MALAYSIA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 622 MALAYSIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 623 MALAYSIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 624 MALAYSIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 625 MALAYSIA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 626 MALAYSIA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 627 MALAYSIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 628 MALAYSIA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 629 MALAYSIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 630 MALAYSIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 631 MALAYSIA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 632 MALAYSIA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 633 MALAYSIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 634 MALAYSIA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 635 MALAYSIA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 636 MALAYSIA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 637 MALAYSIA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 638 MALAYSIA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 639 MALAYSIA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 640 MALAYSIA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 641 NEW ZEALAND PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 642 NEW ZEALAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 643 NEW ZEALAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 644 NEW ZEALAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 645 NEW ZEALAND PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 646 NEW ZEALAND MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 647 NEW ZEALAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 648 NEW ZEALAND NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 649 NEW ZEALAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 650 NEW ZEALAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 651 NEW ZEALAND RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 652 NEW ZEALAND PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 653 NEW ZEALAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 654 NEW ZEALAND GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 655 NEW ZEALAND PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 656 NEW ZEALAND PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 657 NEW ZEALAND OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 658 NEW ZEALAND RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 659 NEW ZEALAND PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 660 NEW ZEALAND HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 661 INDONESIA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 662 INDONESIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 663 INDONESIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 664 INDONESIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 665 INDONESIA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 666 INDONESIA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 667 INDONESIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 668 INDONESIA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 669 INDONESIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 670 INDONESIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 671 INDONESIA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 672 INDONESIA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 673 INDONESIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 674 INDONESIA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 675 INDONESIA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 676 INDONESIA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 677 INDONESIA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 678 INDONESIA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 679 INDONESIA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 680 INDONESIA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 681 VIETNAM PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 682 VIETNAM HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 683 VIETNAM PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 684 VIETNAM PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 685 VIETNAM PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 686 VIETNAM MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 687 VIETNAM ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 688 VIETNAM NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 689 VIETNAM HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 690 VIETNAM HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 691 VIETNAM RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 692 VIETNAM PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 693 VIETNAM ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 694 VIETNAM GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 695 VIETNAM PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 696 VIETNAM PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 697 VIETNAM OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 698 VIETNAM RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 699 VIETNAM PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 700 VIETNAM HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 701 PHILIPPINES PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 702 PHILIPPINES HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 703 PHILIPPINES PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 704 PHILIPPINES PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 705 PHILIPPINES PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 706 PHILIPPINES MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 707 PHILIPPINES ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 708 PHILIPPINES NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 709 PHILIPPINES HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 710 PHILIPPINES HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 711 PHILIPPINES RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 712 PHILIPPINES PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 713 PHILIPPINES ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 714 PHILIPPINES GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 715 PHILIPPINES PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 716 PHILIPPINES PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 717 PHILIPPINES OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 718 PHILIPPINES RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 719 PHILIPPINES PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 720 PHILIPPINES HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 721 REST OF ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 722 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)

TABLE 723 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 724 MIDDLE EAST AND AFRICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 725 MIDDLE EAST AND AFRICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 726 MIDDLE EAST AND AFRICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 727 MIDDLE EAST AND AFRICA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 728 MIDDLE EAST AND AFRICA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 729 MIDDLE EAST AND AFRICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 730 MIDDLE EAST AND AFRICA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 731 MIDDLE EAST AND AFRICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 732 MIDDLE EAST AND AFRICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 733 MIDDLE EAST AND AFRICA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 734 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 735 MIDDLE EAST AND AFRICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 736 MIDDLE EAST AND AFRICA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 737 MIDDLE EAST AND AFRICA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 738 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 739 MIDDLE EAST AND AFRICA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 740 MIDDLE EAST AND AFRICA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 741 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 742 MIDDLE EAST AND AFRICA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 743 SOUTH AFRICA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 744 SOUTH AFRICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 745 SOUTH AFRICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 746 SOUTH AFRICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 747 SOUTH AFRICA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 748 SOUTH AFRICA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 749 SOUTH AFRICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 750 SOUTH AFRICA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 751 SOUTH AFRICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 752 SOUTH AFRICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 753 SOUTH AFRICA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 754 SOUTH AFRICA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 755 SOUTH AFRICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 756 SOUTH AFRICA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 757 SOUTH AFRICA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 758 SOUTH AFRICA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 759 SOUTH AFRICA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 760 SOUTH AFRICA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 761 SOUTH AFRICA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 762 SOUTH AFRICA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 763 SAUDI ARABIA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 764 SAUDI ARABIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 765 SAUDI ARABIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 766 SAUDI ARABIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 767 SAUDI ARABIA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 768 SAUDI ARABIA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 769 SAUDI ARABIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 770 SAUDI ARABIA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 771 SAUDI ARABIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 772 SAUDI ARABIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 773 SAUDI ARABIA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 774 SAUDI ARABIA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 775 SAUDI ARABIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 776 SAUDI ARABIA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 777 SAUDI ARABIA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 778 SAUDI ARABIA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 779 SAUDI ARABIA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 780 SAUDI ARABIA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 781 SAUDI ARABIA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 782 SAUDI ARABIA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 783 U.A.E. PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 784 U.A.E. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 785 U.A.E. PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 786 U.A.E. PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 787 U.A.E. PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 788 U.A.E. MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 789 U.A.E. ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 790 U.A.E. NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 791 U.A.E. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 792 U.A.E. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 793 U.A.E. RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 794 U.A.E. PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 795 U.A.E. ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 796 U.A.E. GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 797 U.A.E. PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 798 U.A.E. PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 799 U.A.E. OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 800 U.A.E. RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 801 U.A.E. PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 802 U.A.E. HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 803 ISRAEL PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 804 ISRAEL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 805 ISRAEL PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 806 ISRAEL PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 807 ISRAEL PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 808 ISRAEL MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 809 ISRAEL ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 810 ISRAEL NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 811 ISRAEL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 812 ISRAEL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 813 ISRAEL RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 814 ISRAEL PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 815 ISRAEL ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 816 ISRAEL GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 817 ISRAEL PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 818 ISRAEL PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 819 ISRAEL OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 820 ISRAEL RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 821 ISRAEL PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 822 ISRAEL HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 823 QATAR PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 824 QATAR HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 825 QATAR PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 826 QATAR PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 827 QATAR PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 828 QATAR MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 829 QATAR ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 830 QATAR NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 831 QATAR HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 832 QATAR HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 833 QATAR RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 834 QATAR PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 835 QATAR ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 836 QATAR GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 837 QATAR PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 838 QATAR PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 839 QATAR OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 840 QATAR RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 841 QATAR PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 842 QATAR HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 843 KUWAIT PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 844 KUWAIT HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 845 KUWAIT PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 846 KUWAIT PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 847 KUWAIT PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 848 KUWAIT MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 849 KUWAIT ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 850 KUWAIT NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 851 KUWAIT HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 852 KUWAIT HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 853 KUWAIT RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 854 KUWAIT PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 855 KUWAIT ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 856 KUWAIT GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 857 KUWAIT PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 858 KUWAIT PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 859 KUWAIT OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 860 KUWAIT RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 861 KUWAIT PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 862 KUWAIT HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 863 EGYPT PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 864 EGYPT HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 865 EGYPT PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 866 EGYPT PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 867 EGYPT PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 868 EGYPT MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 869 EGYPT ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 870 EGYPT NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 871 EGYPT HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 872 EGYPT HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 873 EGYPT RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 874 EGYPT PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 875 EGYPT ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 876 EGYPT GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 877 EGYPT PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 878 EGYPT PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 879 EGYPT OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 880 EGYPT RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 881 EGYPT PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 882 EGYPT HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 883 OMAN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 884 OMAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 885 OMAN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 886 OMAN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 887 OMAN PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 888 OMAN MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 889 OMAN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 890 OMAN NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 891 OMAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 892 OMAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 893 OMAN RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 894 OMAN PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 895 OMAN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 896 OMAN GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 897 OMAN PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 898 OMAN PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 899 OMAN OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 900 OMAN RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 901 OMAN PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 902 OMAN HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 903 BAHRAIN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 904 BAHRAIN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 905 BAHRAIN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 906 BAHRAIN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 907 BAHRAIN MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 908 BAHRAIN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 909 BAHRAIN NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 910 BAHRAIN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 911 BAHRAIN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 912 BAHRAIN RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 913 BAHRAIN PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 914 BAHRAIN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 915 BAHRAIN GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 916 BAHRAIN PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 917 BAHRAIN PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 918 BAHRAIN OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 919 BAHRAIN RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 920 BAHRAIN PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 921 BAHRAIN HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 922 REST OF MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 923 SOUTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)

TABLE 924 SOUTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 925 SOUTH AMERICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 926 SOUTH AMERICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 927 SOUTH AMERICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 928 SOUTH AMERICA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 929 SOUTH AMERICA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 930 SOUTH AMERICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 931 SOUTH AMERICA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 932 SOUTH AMERICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 933 SOUTH AMERICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 934 SOUTH AMERICA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 935 SOUTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 936 SOUTH AMERICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 937 SOUTH AMERICA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 938 SOUTH AMERICA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 939 SOUTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 940 SOUTH AMERICA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 941 SOUTH AMERICA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 942 SOUTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 943 SOUTH AMERICA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 944 BRAZIL PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 945 BRAZIL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 946 BRAZIL PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 947 BRAZIL PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 948 BRAZIL PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 949 BRAZIL MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 950 BRAZIL ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 951 BRAZIL NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 952 BRAZIL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 953 BRAZIL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 954 BRAZIL RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 955 BRAZIL PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 956 BRAZIL ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 957 BRAZIL GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 958 BRAZIL PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 959 BRAZIL PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 960 BRAZIL OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 961 BRAZIL RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 962 BRAZIL PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 963 BRAZIL HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 964 ARGENTINA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 965 ARGENTINA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 966 ARGENTINA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 967 ARGENTINA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)

TABLE 968 ARGENTINA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 969 ARGENTINA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 970 ARGENTINA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)

TABLE 971 ARGENTINA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 972 ARGENTINA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)

TABLE 973 ARGENTINA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)

TABLE 974 ARGENTINA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 975 ARGENTINA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)

TABLE 976 ARGENTINA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 977 ARGENTINA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 978 ARGENTINA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)

TABLE 979 ARGENTINA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)

TABLE 980 ARGENTINA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 981 ARGENTINA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 982 ARGENTINA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)

TABLE 983 ARGENTINA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

TABLE 984 REST OF SOUTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)

List of Figure

FIGURE 1 GLOBAL PULMONARY FUNCTION TESTING MARKET: SEGMENTATION

FIGURE 2 GLOBAL PULMONARY FUNCTION TESTING MARKET: DATA TRIANGULATION

FIGURE 3 GLOBAL PULMONARY FUNCTION TESTING MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL PULMONARY FUNCTION TESTING MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 GLOBAL PULMONARY FUNCTION TESTING MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL PULMONARY FUNCTION TESTING MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 GLOBAL PULMONARY FUNCTION TESTING MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 8 GLOBAL PULMONARY FUNCTION TESTING MARKET: DBMR MARKET POSITION GRID

FIGURE 9 GLOBAL PULMONARY FUNCTION TESTING MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 GLOBAL PULMONARY FUNCTION TESTING MARKET: SEGMENTATION

FIGURE 11 GLOBAL PULMONARY FUNCTION TESTING MARKET, BY TYPE

FIGURE 12 EXECUTIVE SUMMARY

FIGURE 13 STRATEGIC DECISIONS

FIGURE 14 INCREASING PREVALENCE OF RESPIRATORY DISEASES IS DRIVING THE GROWTH OF THE GLOBAL PULMONARY FUNCTION TESTING MARKET FROM 2024 TO 2031

FIGURE 15 THE HARDWARE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL PULMONARY FUNCTION TESTING MARKET IN 2024 AND 2031

FIGURE 16 DROC ANALYSIS

FIGURE 17 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY TYPE, 2023

FIGURE 18 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY TYPE, 2024-2031 (USD THOUSAND)

FIGURE 19 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY TYPE, CAGR (2024-2031)

FIGURE 20 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY TYPE, LIFELINE CURVE

FIGURE 21 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, 2023

FIGURE 22 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, 2024-2031 (USD THOUSAND)

FIGURE 23 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, CAGR (2024-2031)

FIGURE 24 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, LIFELINE CURVE

FIGURE 25 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY APPLICATION 2023

FIGURE 26 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY APPLICATION, 2024-2031 (USD THOUSAND)

FIGURE 27 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY APPLICATION, CAGR (2024-2031)

FIGURE 28 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 29 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY END USER 2023

FIGURE 30 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY END USER, 2024-2031 (USD THOUSAND)

FIGURE 31 GLOBAL PULMONARY FUNCTION TESTING MARKET: END USER, CAGR (2024-2031)

FIGURE 32 GLOBAL PULMONARY FUNCTION TESTING MARKET: END USER, LIFELINE CURVE

FIGURE 33 GLOBAL PULMONARY FUNCTION TESTING MARKET: SNAPSHOT (2023)

FIGURE 34 GLOBAL PULMONARY FUNCTION TESTING MARKET: COMPANY SHARE 2023 (%)

FIGURE 35 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET: COMPANY SHARE 2023 (%)

FIGURE 36 EUROPE MEDICAL IMAGE MANAGEMENT MARKET: COMPANY SHARE 2023 (%)

FIGURE 37 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: COMPANY SHARE 2023 (%)

View Detailed Information Right Arrow

منهجية البحث

يتم جمع البيانات وتحليل سنة الأساس باستخدام وحدات جمع البيانات ذات أحجام العينات الكبيرة. تتضمن المرحلة الحصول على معلومات السوق أو البيانات ذات الصلة من خلال مصادر واستراتيجيات مختلفة. تتضمن فحص وتخطيط جميع البيانات المكتسبة من الماضي مسبقًا. كما تتضمن فحص التناقضات في المعلومات التي شوهدت عبر مصادر المعلومات المختلفة. يتم تحليل بيانات السوق وتقديرها باستخدام نماذج إحصائية ومتماسكة للسوق. كما أن تحليل حصة السوق وتحليل الاتجاهات الرئيسية هي عوامل النجاح الرئيسية في تقرير السوق. لمعرفة المزيد، يرجى طلب مكالمة محلل أو إرسال استفسارك.

منهجية البحث الرئيسية التي يستخدمها فريق بحث DBMR هي التثليث البيانات والتي تتضمن استخراج البيانات وتحليل تأثير متغيرات البيانات على السوق والتحقق الأولي (من قبل خبراء الصناعة). تتضمن نماذج البيانات شبكة تحديد موقف البائعين، وتحليل خط زمني للسوق، ونظرة عامة على السوق ودليل، وشبكة تحديد موقف الشركة، وتحليل براءات الاختراع، وتحليل التسعير، وتحليل حصة الشركة في السوق، ومعايير القياس، وتحليل حصة البائعين على المستوى العالمي مقابل الإقليمي. لمعرفة المزيد عن منهجية البحث، أرسل استفسارًا للتحدث إلى خبراء الصناعة لدينا.

التخصيص متاح

تعد Data Bridge Market Research رائدة في مجال البحوث التكوينية المتقدمة. ونحن نفخر بخدمة عملائنا الحاليين والجدد بالبيانات والتحليلات التي تتطابق مع هدفهم. ويمكن تخصيص التقرير ليشمل تحليل اتجاه الأسعار للعلامات التجارية المستهدفة وفهم السوق في بلدان إضافية (اطلب قائمة البلدان)، وبيانات نتائج التجارب السريرية، ومراجعة الأدبيات، وتحليل السوق المجدد وقاعدة المنتج. ويمكن تحليل تحليل السوق للمنافسين المستهدفين من التحليل القائم على التكنولوجيا إلى استراتيجيات محفظة السوق. ويمكننا إضافة عدد كبير من المنافسين الذين تحتاج إلى بيانات عنهم بالتنسيق وأسلوب البيانات الذي تبحث عنه. ويمكن لفريق المحللين لدينا أيضًا تزويدك بالبيانات في ملفات Excel الخام أو جداول البيانات المحورية (كتاب الحقائق) أو مساعدتك في إنشاء عروض تقديمية من مجموعات البيانات المتوفرة في التقرير.

Frequently Asked Questions

يتم تقسيم السوق بناءً على تجزئة سوق اختبار وظائف الرئة العالمي، حسب النوع (الأجهزة، الخدمات، والبرمجيات)، نوع المريض (أطفال، بالغون، وكبار السن)، التطبيق (مرض الانسداد الرئوي ومرض الرئة التقييدي)، المستخدم النهائي (المستشفيات، العيادات التخصصية، مختبرات التشخيص، مؤسسات الرعاية المنزلية، وغيرها) - اتجاهات الصناعة وتوقعاتها حتى عام 2032 .
تم تقييم حجم تقرير تحليل حجم السوق بمبلغ 3.88 USD Billion دولارًا أمريكيًا في عام 2024.
من المتوقع أن ينمو تقرير تحليل حجم السوق بمعدل نمو سنوي مركب قدره 6.1% خلال فترة التوقعات من 2025 إلى 2032.
تشمل الشركات الكبرى العاملة في السوق BD , SCHILLER CoSMED srl , NSPIRE Healthcare , MGC DIAGNOSTICS CORPORATION , ndd Medical Technologies , Morgan ScientificInc. , Ganshorn Medizin Electronic GmbH , Minato Holdings Inc. , CHEST M.I.Inc. , Koninklijke Philips N.V. , medical equipment europe GmbH , Omron HealthcareInc. , Medtronic .
Testimonial